Jci_page_head_homepage_01 Jci_page_head_homepage_02
Stephen C. Benoit, Christopher J. Kemp, Carol F. Elias, William Abplanalp, James P. Herman, Stephanie Migrenne, Anne-Laure Lefevre, Céline Cruciani-Guglielmacci, Christophe Magnan, Fang Yu, Kevin Niswender, Boman G. Irani, William L. Holland, Deborah J. Clegg
Published in Volume 119, Issue 9
J Clin Invest. 2009; 119(9):2577–2589 doi:10.1172/JCI36714
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
i.c.v. palmitic acid (but not oleic acid) attenuates insulin-induced suppression of hepatic glucose production.

Rats (6–8/group) received a 3-day i.c.v. infusion of palmitic acid, oleic acid, or control (cont) (PBS), before a carotid-artery insulin infusion under euglycemic clamp conditions. Comparable glucose use rates (~100 mg/dl) were achieved in all groups, beginning 90 minutes after the start of the experiment. All groups had plasma insulin values of approximately 900 pmol/l (data not shown). Carotid insulin infusions reduced hepatic glucose production in control and oleic acid–infused rats but not in rats infused with palmitic acid (data are mean ± SEM; ***P < 0.001 compared with control infusions).